IFPAC 2024

The IFPAC conference features discussions on the latest technological and regulatory solutions in biotechnology. It offers a platform for regulators, industry leaders, and academics to discuss trends and applications in Quality by Design, Process Analytical Technology, and Continuous Manufacturing.

DiscoverBMB

The DiscoverBMB conference aims to share the latest and most significant research findings in molecular life sciences.

Bioprocess International US West

The Bioprocess International US West conference features over 200 industry-leading scientists discussing the latest developments in biopharmaceutical efficiency, attracting a large and diverse international audience. This event focuses on all phases of biopharmaceutical development and production.

Biophysical Society 2024

The Biophysical Society’s annual meeting highlights significant advances in biophysics, showcasing breakthroughs in drug development and protein structure prediction, and featuring discussions on the complexity of cellular membranes and genomic organization.

SLAS 2024

The SLAS International Conference and Exhibition is a significant event featuring over 150 scientific talks across 9 educational tracks, focusing on advancement in the life sciences, technology, and laboratory automation, attracting a diverse group of scientists and academics.

WCBP Symposium

The WCBP CASSS conference is an annual event for sharing advances in analytical technology and regulatory science in biopharmaceuticals.

Advanced Therapies Week

Advanced Therapies Week is a dynamic event featuring networking opportunities and thought provoking content focusing on the future of cell and gene therapy.

Gene Therapy & Analytical Development 2023

Gene Therapy Analytical Development will unite innovative biotech and pharma organizations to discuss the development of robust analytical tools to guarantee the consistency, quality, and safety of gene therapy products.

The 6th Targeted Degradation Summit

The 6th Targeted Protein Degradation Summit will return to once again explore the latest approaches, perspectives, and data-driven case studies that will continue to advance PROTACs, molecular glues, and other degrader modalities towards clinical success.